Immuno-Biological Laboratories Co., Ltd.(JP:4570)
Â¥974.00-10.00 (-1.02%)
JP:4570
Immuno-Biological Laboratories Co., Ltd. Revenue
Â¥974.00
At close:-10.00 (-1.02%)
Want to see JP:4570 full AI Analyst Report?
Immuno-Biological Laboratories Co., Ltd. (4570) Revenue
0 Followers
Immuno-Biological Laboratories Co., Ltd. Revenue
Immuno-Biological Laboratories Co., Ltd. had a revenue of 286.01M in the quarter ending Jun 30, 2026, with 8.83%. This bring the company's revenue in the last twelve months to 1.08B, Increased 7.42%. In the fiscal year ending Mar 31, 2026, Immuno-Biological Laboratories Co., Ltd. had annual revenue of 1.00B with 3.66% growth.
- Revenue (ttm)
- 1.08B
- Revenue Growth
- 7.10%
- P/S Ratio
- 9.12
- Revenue/Employee
- JPY 18,610,870
- Employees
- 54
- Market Cap
- JPY 9.16B
Revenue Chart
Immuno-Biological Laboratories Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.00B | 35.45M | 3.66% |
| Mar 31, 2025 | 969.53M | 152.83M | 18.71% |
| Mar 31, 2024 | 816.70M | 22.08M | 2.78% |
| Mar 31, 2023 | 794.62M | 147.04M | 22.71% |
| Mar 31, 2022 | 647.58M | 44.83M | 7.44% |
| Mar 31, 2021 | 602.75M | 26.75M | 4.64% |
| Mar 31, 2020 | 576.00M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.